Dokument: Extracellular Vesicles as Markers of Liver Function: Optimized Workflow for Biomarker Identification in Liver Disease

Titel:Extracellular Vesicles as Markers of Liver Function: Optimized Workflow for Biomarker Identification in Liver Disease
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=67091
URN (NBN):urn:nbn:de:hbz:061-20241017-132500-1
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Paluschinski, Martha [Autor]
Loosen, Sven H. [Autor]
Kordes, Claus [Autor]
Keitel, Verena [Autor]
Kuebart, Anne [Autor]
Brandenburger, Timo [Autor]
Schöler, David [Autor]
Wammers, Marianne [Autor]
Luedde, Tom [Autor]
Castoldi, Mirco [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]1,63 MB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 17.10.2024 / geändert 17.10.2024
Stichwörter:cytokine, liver diseases, biomarker, microRNA, nanoparticle-tracking analysis, extracellular vesicles
Beschreibung:Liver diseases represent a significant global health burden, necessitating the development of reliable biomarkers for early detection, prognosis, and therapeutic monitoring. Extracellular vesicles (EVs) have emerged as promising candidates for liver disease biomarkers due to their unique cargo composition, stability, and accessibility in various biological fluids. In this study, we present an optimized workflow for the identification of EVs-based biomarkers in liver disease, encompassing EVs isolation, characterization, cargo analysis, and biomarker validation. Here we show that the levels of microRNAs miR-10a, miR-21, miR-142-3p, miR-150, and miR-223 were different among EVs isolated from patients with nonalcoholic fatty liver disease and autoimmune hepatitis. In addition, IL2, IL8, and interferon-gamma were found to be increased in EVs isolated from patients with cholangiocarcinoma compared with healthy controls. By implementing this optimized workflow, researchers and clinicians can improve the identification and utilization of EVs-based biomarkers, ultimately enhancing liver disease diagnosis, prognosis, and personalized treatment strategies.
Rechtliche Vermerke:Originalveröffentlichung:
Paluschinski, M., Loosen, S. H., Kordes, C., Keitel-Anselmino, V., Kuebart, A., Brandenburger, T., Schöler, D., Wammers, M., Neumann, U. P., Lüdde, T., & Castoldi, M. (2023). Extracellular Vesicles as Markers of Liver Function: Optimized Workflow for Biomarker Identification in Liver Disease [OnlineRessource]. International Journal of Molecular Sciences, 24(11), Article 9631. https://doi.org/10.3390/ijms24119631
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:17.10.2024
Dateien geändert am:17.10.2024
english
Benutzer
Status: Gast
Aktionen